Pharmaceutical Companies

As the global population ages, the rise in cognitive disorders like dementia poses significant challenges to healthcare systems. Researchers have developed an innovative AI-based...

With the surge in global aging, cognitive disorders like dementia are becoming increasingly prevalent. Early detection plays a vital role in managing these conditions...

As the global population ages, the rising cases of cognitive disorders like dementia are becoming a critical public health concern. Medical professionals are increasingly...

As the global population ages, the surge in cognitive disorders like dementia demands innovative solutions. A recent study introduces a groundbreaking method leveraging artificial...

As the global population ages, the rise in cognitive disorders like dementia necessitates more efficient diagnostic tools. Researchers have developed an intelligent electronic cognitive...

AbbVie's ELAHERE® (mirvetuximab soravtansine-gynx) has demonstrated a significant survival advantage over traditional chemotherapy in patients with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer, according...

Photocure ASA, known as the Bladder Cancer Company, has announced the publication of its BRAVO study in JU Open Plus. This research highlights significant...

ANI Pharmaceuticals has achieved a significant milestone with the U.S. Food and Drug Administration's (FDA) approval to broaden the indications for its flagship product,...

As the global population ages, the rise in cognitive disorders like dementia poses significant challenges for healthcare systems worldwide. Recent advancements in artificial intelligence...

The Institute for Clinical and Economic Review (ICER) has initiated a comprehensive assessment of brensocatib, targeting the treatment of non-cystic fibrosis bronchiectasis (NCFB). This...

Bayer is set to present groundbreaking findings on elinzanetant, a late-stage compound targeting menopause symptoms, at the 16th Congress of the European Society of...

Zai Lab Limited has announced that China's National Medical Products Administration (NMPA) has accepted its Biologics License Application (BLA) for TIVDAK, aimed at treating...

Shionogi unveiled promising results from the SCORPIO-PEP Phase 3 trial, demonstrating that Ensitrelvir effectively reduces the risk of developing COVID-19 after exposure. This oral...

Grifols has reported promising outcomes from its Phase 2/3 clinical trial, demonstrating that its intravenous immunoglobulin (IVIG) treatment significantly improves walking distance in individuals...

Amgen Technology (Ireland) UC has officially retracted its marketing authorization application for the biosimilar medicine Skojoy in the European Union. The withdrawal took effect...